Methicillin Resistant Staphylococci: Prevalence and susceptibility patterns in a burn center in Ahvaz from 2013-2014
Abstract
Background and Objectives: Methicillin resistance Staphylococcus aureus (MRSA) and coagulase negative staphylococci (MRCoNS) have recognized as the major cause of nosocomial infections that threat the burn patient’s life. The aims of this study were to determine the frequency of MRSA and MRCoNS and their antibiotic resistance patterns among burn patients in a burn center in Ahvaz, Iran.
Material and Methods: A total of 340 clinical specimens: (80%) wound and (20%) blood were obtained from patients in Taleghani burn hospital during February 2013-2014. Staphylococci species identification and antibiogram were performed by standard procedures using disk diffusion method. The Methicillin resistance strains were detected by Etest and PCR using mecA specific primers.
Results: Out of 30.2% (103) isolates that were recognized as staphylococci, 82 % (84) and 18% (19) were identified as S. aureus and coagulase negative staphylococci (CoNS) respectively. Resistance to methicillin was detected in 60% and 63% of the S. aureus and CoNS isolates respectively. Seven different antimicrobial resistance patterns observed among methicillin resistant staphylococci. The MRSA and MRCoNS strains showed closed resistance phenotypes. All the methicillin resistant isolates showed a high rate resistance to the other studied antibiotics in comparison to methicilin sensitive isolates. Vancomy- cin and imipenem showed the greatest effect against methicillin resistant isolates. During 8 years in the studied burn hospital, no significant changes in the methicillin resistance staphylococci frequency were detected.
Conclusion: The presence of multi resistant MRSA and MRCoNS strains is cause of concern in burn hospitals. Vancomycin remains as a drug of choice for methicillin resistance staphylococci infections.
Boyce JM, Landry M, Deetz TR, Dupont HL. Epidemi- ologic studies of an outbreak of nosocomial methicil- lin- resistant Staphylococcus aureus infections. Infect Control 1981; 2:110–116.
Reardon CM, Brown TP, Stephenson AJ, Freedland- er E. Methicillin-resistant Staphylococcus aureus in burns patients-why all the fuss? Burns 1998;24 :393–397.
Roth RR, James WD. Treatment of infections due to coagulase-negative staphylococci. Annu Rev Microbi- ol 1988; 42: 441.
Palavecino E. Clinical, epidemiological and laborato- ry aspects of methicillin-resistant Staphylococcus au- reus (MRSA) infections. Methicillin-Resistant Staph- ylococcus aureus (MRSA) Protocols. Humana Press,2007: 1-19.
Barlow Y. T lymphocytes and immunosuppression in the burned patient: a review. Burns 1994; 20: 487-490.
Ruef C. Epidemiology and clinical impact of glyco- peptide resistance in Staphylococcus aureus. Infection 2004; 32:315–27.
Furuno JP, Perencevich EN, Johnson JA, Wright MO, McGregor JC, Morris JR, et al. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant en- terococci co-colonization. Emerg Infect Dis 2005; 11: 1539-1544.
Ekrami A, Kalantar E. Bacterial infections in burn pa- tients at a burn hospital in Iran. Indian Med Res 2007;12: 541.
Ekrami A, Samarbafzadeh A, Alavi M, Kalantar E, Hamzeloi F. Prevalence of methicillin resistant Staph- ylococcus species isolated from burn patients in a burn center, Ahvaz, Iran. Jundishapur J Microbiol 3.2 (2011): 84-91.
Abbasi Montazeri E, Khosravi A D, Feizabadi M M, Goodarzi H , Khoramrooz S, Mirzaii S, et al. The prevalence of methicillin resistant Staphylococcus aureus (MRSA) isolates with high-level mupirocin re- sistance from patients and personnel in a burn center. Burns 2013; 39:, 650-654.
Baron J, Fingold S. Methods for identification of etho- logic agent of infection disease. Baily & Scotts diag- nostic microbiology. 10 th ed. St. Louis, USA: Mosby, Inc; 1996:327-529.12. CLSI. Performance Standards for Antimicrobial Sus- ceptibility Testing; 21th ed. Wayne, PA: Clinical and Laboratory Standards Institute 2011; 31: 84-87.
Unal S, Hoskins J, Flokowitsh J, Wu C, Preston D, Scatrud P. Detection of methicillin-resistant staphylo- cocci by using the polymerase chain reaction. J Clin Microbiol 1992; 30:1685-91.
Moghadam Ohadian S, Pourmand MR, Aminharati F. "Biofilm formation and antimicrobial resistance in methicillin-resistant Staphylococcus aureus isolated from burn patients, Iran. J Infect Dev Countr 2014; 8:1511-1517.
Thati V, Shivannavar C T, Gaddad SM. Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad. Indian J Med Res 2011;134: 704.
Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover F C, Downes FP, et al. Infection with vanco- mycin-resistant Staphylococcus aureus containing the vanA resistance gene. New England J Med 2003; 348:1342-1347.
Sievert DM, Rudrik JT, Patel JB, McDonald LC, Wilkins MJ, Hageman JC. Vancomycin-resistant Staphylococcus aureus in the United States, 2002–2006. Clin infect 2008; 46: 668-674.
Dezfulian A, Aslani MM, Oskoui M, Farrokh P, Azi- mirad M, Dabiri H, et al. Identification and haracter- ization of a high vancomycin-resistant Staphylococcus aureus harboring vanA gene cluster isolated from dia- betic foot ulcer. Iran J Basic Med Sci 2012; 15: 803.
Askari E, Zarifian A, Pormand MR, Naderi-Nasab M.High-Level Vancomycin-Resistant Staphylococcus aureus (VRSA) in Iran: A Systematic Review. J Med Bacteriol 2012; 1:53-61.
Azimian A, Havaei SA, Fazeli H, Naderi M, Ghazvini K, Mirab Samiee S, et al. Genetic characterization of a vancomycin-resistant Staphylococcus aureus isolated from respiratory tract of a hospitalized patient in a uni- versity hospital in north east of Iran. J Clin Microbiol 2012; 50: 3581-5.
Rahimi F, Bouzari M, Katouli, M, Pourshafie MR (2013). Antibiotic resistance pattern of methicillin resistant and methicillin sensitive Staphylococcus au- reus isolates in Tehran, Iran. Jundishapur J Microbiol 2013; 6: 144-149.
Mayhall CG. Hospital epidemiology and infection control, 3rd ed .Philadelphia: Lippincott Wiliamand Wilkins; 2004 p.495–510.
Huang SY, Tang RN, Chen SY. Coagulase-negative staphylococcal bacteremia in critically ill children: risk factors and antimicrobial susceptibility. J Micro- biol Immunol Infect 2003; 36:51–5.
Knauer A, Fladerer P, Strempfl C. Effect of hospital- ization and antimicrobial therapy on antimicrobial resistance of colonizing Staphylococcus epidermidis. Wien Klin Wochenschr 2004; 116:489–94.
Koksal F, Yasar H, Samasti M. Antibiotic resistance patterns of coagulase-negative staphylococcus strains isolated from blood cultures of septicemic patients in Turkey. Microbiol Res 2009; 164: 404-410.
| Files | ||
| Issue | Vol 7 No 4 (2015) | |
| Section | Articles | |
| Keywords | ||
| Methicillin Resistance Staphylococci Burn patients | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
